OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Showing 15 citing articles:
An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
V. Edwin Hillary, Stanislaus Antony Ceasar
Heliyon (2023) Vol. 9, Iss. 3, pp. e13952-e13952
Open Access | Times Cited: 76
V. Edwin Hillary, Stanislaus Antony Ceasar
Heliyon (2023) Vol. 9, Iss. 3, pp. e13952-e13952
Open Access | Times Cited: 76
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV
Andrea Ricci, Giovanni N. Roviello
Life (2023) Vol. 13, Iss. 2, pp. 402-402
Open Access | Times Cited: 19
Andrea Ricci, Giovanni N. Roviello
Life (2023) Vol. 13, Iss. 2, pp. 402-402
Open Access | Times Cited: 19
COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature
Eleonora Virgilio, Giacomo Tondo, Claudia Montabone, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 20, Iss. 1, pp. 467-467
Open Access | Times Cited: 11
Eleonora Virgilio, Giacomo Tondo, Claudia Montabone, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 20, Iss. 1, pp. 467-467
Open Access | Times Cited: 11
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial
Xiaoqiang Liu, Zhonghan Sun, Zhongfang Wang, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102231-102231
Open Access | Times Cited: 6
Xiaoqiang Liu, Zhonghan Sun, Zhongfang Wang, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102231-102231
Open Access | Times Cited: 6
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease
Monika Peshevska-Sekulovska, Plamena Bakalova, Violeta Snegarova, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2075-2075
Open Access | Times Cited: 6
Monika Peshevska-Sekulovska, Plamena Bakalova, Violeta Snegarova, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2075-2075
Open Access | Times Cited: 6
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell, Francesca L. Mordant, Alberto A. Amarilla, et al.
EBioMedicine (2023) Vol. 97, pp. 104842-104842
Open Access | Times Cited: 2
Keith J. Chappell, Francesca L. Mordant, Alberto A. Amarilla, et al.
EBioMedicine (2023) Vol. 97, pp. 104842-104842
Open Access | Times Cited: 2
A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study
Giorgio Fedele, Ilaria Schiavoni, Filippo Trentini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Giorgio Fedele, Ilaria Schiavoni, Filippo Trentini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2
Davide Cavazzini, Elisabetta Levati, S. Germani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12319-12319
Open Access
Davide Cavazzini, Elisabetta Levati, S. Germani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12319-12319
Open Access
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
Aziz Alami Chentoufi, Jeffrey B. Ulmer, Lbachir BenMohamed
Vaccines (2024) Vol. 13, Iss. 1, pp. 30-30
Open Access
Aziz Alami Chentoufi, Jeffrey B. Ulmer, Lbachir BenMohamed
Vaccines (2024) Vol. 13, Iss. 1, pp. 30-30
Open Access
Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 Cohort
Bárbara Batista Salgado, Aguyda Rayany Cavalcante Barbosa, Ana Ruth Lima Arcanjo, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1987-1987
Open Access | Times Cited: 1
Bárbara Batista Salgado, Aguyda Rayany Cavalcante Barbosa, Ana Ruth Lima Arcanjo, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1987-1987
Open Access | Times Cited: 1
The therapeutic potential of mesenchymal stem cells in COVID-19: Present and future
Mutiara Indah Sari, Imam Budi Putra, Dadik Wahyu Wijaya
Research Results in Pharmacology (2023) Vol. 9, Iss. 2, pp. 74-85
Open Access
Mutiara Indah Sari, Imam Budi Putra, Dadik Wahyu Wijaya
Research Results in Pharmacology (2023) Vol. 9, Iss. 2, pp. 74-85
Open Access
Cutaneous Reactions to Non-mRNA COVID-19 Vaccines
Pawinee Rerknimitr, Chanudda Washrawirul, Jidapa Triwatcharikorn
Updates in clinical dermatology (2023), pp. 31-40
Closed Access
Pawinee Rerknimitr, Chanudda Washrawirul, Jidapa Triwatcharikorn
Updates in clinical dermatology (2023), pp. 31-40
Closed Access
Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2
Kevin Chiem, Aitor Nogales, Fernando Almazán, et al.
Methods in molecular biology (2023), pp. 133-153
Closed Access
Kevin Chiem, Aitor Nogales, Fernando Almazán, et al.
Methods in molecular biology (2023), pp. 133-153
Closed Access
